Products Affected - Description
Ephedrine 50 mg/mL, injection, Sandoz
1 mL vial, 25 count (NDC 66758-0008-02)
Reason for the Shortage
Hospira discontinued ephedrine in March, 2011.
Ephedrine 50 mg/mL, injection, Akorn
1 mL ampule, 10 count (NDC 17478-0515-00)
Estimated Resupply Dates
Sandoz has ephedrine 1 mL vials on back order and the company estimates a release date of mid- to late-January 2015.
December 16, 2014; November 21, 2014; October 13, 2014; October 2, 2014; August 20, 2014; July 25, 2014; June 26, 2014; June 6, 2014; May 13, 2014; May 7, 2014; April 24, 2014; March 18, 2014, University of Utah, Drug Information Service. Copyright 2014, University of Utah, Drug Information Service.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins